Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Revenue

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MARKSANS PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹2,623 Cr₹2,177 Cr₹1,852 Cr₹1,491 Cr₹1,376 Cr

What is the latest Revenue of MARKSANS PHARMA ?

The latest Revenue ratio of MARKSANS PHARMA is ₹2,623 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹2,623 Cr
Mar2024₹2,177 Cr
Mar2023₹1,852 Cr
Mar2022₹1,491 Cr
Mar2021₹1,376 Cr

How is Revenue of MARKSANS PHARMA Trending?

Years Revenue % Change
Mar2025 ₹2,623 Cr
20.46
Mar2024 ₹2,177 Cr
17.56
Mar2023 ₹1,852 Cr
24.23
Mar2022 ₹1,491 Cr
8.33
Mar2021 ₹1,376 Cr -

Compare Revenue of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,493.7 Cr 2.5% -7.6% -24% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

2.5%

-7.6%

-24%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses